Why is P & G Health Ltd falling/rising?

As of 19-Aug, Procter & Gamble Health Ltd's stock price is rising, currently at 6,305.50, reflecting an increase of 92.6 (1.49%). The stock is trading close to its 52-week high, just 2.93% away, and has outperformed its sector by 1.62% today. It is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong momentum. Additionally, the stock has shown positive performance over the past month with a return of 7.37%, significantly outperforming the benchmark Sensex, which has seen a slight decline of 0.14%. The company has demonstrated high management efficiency with a return on equity (ROE) of 32.32%, low debt levels, and consistent positive results over the last four quarters, contributing to investor confidence and rising participation.
In the broader market context, while the Sensex has generated a return of 1.76% over the past week, Procter & Gamble Health Ltd has experienced a decline of 0.75% in the same period, suggesting that the stock's recent rise is more reflective of its individual performance rather than overall market trends. Despite the stock's strong annual return of 19.76% compared to the benchmark's 1.52%, concerns about its long-term growth potential remain, as net sales and operating profit growth rates are relatively modest. However, the stock's attractive valuation compared to peers and high institutional holdings indicate a favorable outlook, which may be driving the current upward movement.